trial
as of 2026-07-01SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study
NCTId NCT06568081
at a glance
— · Recruiting
Enrollment 150 (estimated)
Sponsored by King's College London
Primary completion 2027-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
150 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-10-16
Primary completion
2027-09
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
King's College LondonLead Sponsor
South London and Maudsley NHS Foundation TrustCollaborator
Sussex Partnership NHS Foundation TrustCollaborator
Investigators
1
Amy HardyPrincipal Investigator
Sites
1 total
London, United Kingdom
Facts & assertions
4 sourced
Enrollment
150
Phase
NA
Primary Completion Date
2027-09
Status
RECRUITING
relationships
The graph out of here
drug
drug
lead_sponsor
company
collaborator
indication
investigator
person